193 related articles for article (PubMed ID: 19374919)
1. New targets and therapeutic approaches for endocrine malignancies.
Fassnacht M; Kreissl MC; Weismann D; Allolio B
Pharmacol Ther; 2009 Jul; 123(1):117-41. PubMed ID: 19374919
[TBL] [Abstract][Full Text] [Related]
2. New molecular targeted therapies in thyroid cancer.
Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
[TBL] [Abstract][Full Text] [Related]
3. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Oncol; 2008 Jan; 20(1):19-24. PubMed ID: 18043252
[TBL] [Abstract][Full Text] [Related]
4. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
Santarpia L; Ye L; Gagel RF
J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy in radioiodine refractory thyroid cancer.
Pacini F; Brilli L; Marchisotta S
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
[TBL] [Abstract][Full Text] [Related]
6. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.
Ye L; Santarpia L; Gagel RF
Endocr Rev; 2010 Aug; 31(4):578-99. PubMed ID: 20605972
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy of thyroid cancer.
Sherman SI
Biochem Pharmacol; 2010 Sep; 80(5):592-601. PubMed ID: 20471374
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
Sbiera S; Wortmann S; Fassnacht M
Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for endocrine cancer: the medullary thyroid carcinoma paradigm.
Ye L; Santarpia L; Gagel RF
Endocr Pract; 2009; 15(6):597-604. PubMed ID: 19546050
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic thyroid cancer: a comprehensive review of novel therapy.
Kojic SL; Strugnell SS; Wiseman SM
Expert Rev Anticancer Ther; 2011 Mar; 11(3):387-402. PubMed ID: 21417853
[TBL] [Abstract][Full Text] [Related]
11. Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives.
Capurso G; Fazio N; Festa S; Panzuto F; De Braud F; Delle Fave G
Crit Rev Oncol Hematol; 2009 Nov; 72(2):110-24. PubMed ID: 19249226
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies].
Malouf G; Baudin E; Soria JC; Schlumberger M
Bull Cancer; 2009 Jan; 96(1):95-101. PubMed ID: 19211364
[TBL] [Abstract][Full Text] [Related]
13. The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies.
Kondapalli L; Soltani K; Lacouture ME
J Am Acad Dermatol; 2005 Aug; 53(2):291-302. PubMed ID: 16021125
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted therapies for patients with refractory thyroid cancer.
Chougnet C; Brassard M; Leboulleux S; Baudin E; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):448-55. PubMed ID: 20554167
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeted therapy for neuroendocrine tumors.
Yao JC; Hoff PM
Hematol Oncol Clin North Am; 2007 Jun; 21(3):575-81; x. PubMed ID: 17548041
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapies for thyroid carcinoma.
Walsh S; Prichard R; Hill AD
Surgeon; 2012 Feb; 10(1):53-8. PubMed ID: 22233555
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic approaches to treat medullary thyroid carcinoma.
Schlumberger M; Carlomagno F; Baudin E; Bidart JM; Santoro M
Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):22-32. PubMed ID: 18084343
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches in the treatment of systemic mastocytosis.
Quintas-Cardama A; Aribi A; Cortes J; Giles FJ; Kantarjian H; Verstovsek S
Cancer; 2006 Oct; 107(7):1429-39. PubMed ID: 16948123
[TBL] [Abstract][Full Text] [Related]
19. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the efficacy of hormonal agents with selected targeted agents.
Johnston SR
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S28-36. PubMed ID: 19561004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]